Integra LifeSciences Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.11.24	Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research (GlobeNewswire)
04.11.24	Integra LifeSciences Trims Outlook; Q2 Results Top Estimates; Names Mojdeh Poul As President And CEO (RTTNews)
29.07.24	Integra Lifesciences Slashes Annual Guidance Below Consensus - Update (RTTNews)
06.05.24	Integra LifeSciences Turns To Net Loss In Q1; Adj. Profit In Line; Revises Annual Guidance (RTTNews)
28.02.24	Integra LifeSciences Q4 Adj. Profit Declines, Organic Revenues Down 1.2%; Jan De Witte To Retire (RTTNews)
13.12.23	Integra LifeSciences To Acquire Acclarent For $275 Mln Cash (RTTNews)
07.11.23	ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
31.10.23	ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
25.10.23	ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
16.10.23	ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
09.10.23	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
03.10.23	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
25.09.23	IART LOSS ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
16.09.23	ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Integra LifeSciences Holdings Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IART (PR Newswire)
03.06.23	ROSEN, A TOP RANKED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Inquire About Securities Class Action Investigation - IART (PR Newswire)
27.05.23	IART INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Inquire About Securities Class Action Investigation - IART (PR Newswire)
26.04.23	Integra LifeSciences Q1 Adj. EPS Meets View, Revenues Beat; Sees Q2 Below Market; Backs FY23 View (RTTNews)
22.02.23	Integra LifeSciences Q4 Profit Beats Estimates; Revenues Up 2.9% On Organic Basis (RTTNews)
26.10.22	Integra LifeSciences Q3 Profit Beats Estimates (RTTNews)
27.07.22	Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates (RTTNews)
27.04.22	Integra LifeSciences Reaffirms FY22 Adj. EPS, Revenue Outlook; Q1 Results Top Estimates (RTTNews)
23.02.22	Integra LifeSciences Q4 Profit Tops Estimates; Revenues Up 8.3% On Organic Basis (RTTNews)
02.11.21	Integra LifeSciences Report Upbeat Q3 Results; Raises Full-year Earnings Outlook (RTTNews)
28.07.21	Integra LifeSciences Boosts FY21 Outlook - Quick Facts (RTTNews)
28.04.21	Integra LifeSciences Q1 Profit Tops Estimates (RTTNews)
18.02.21	Integra LifeSciences Guides FY21 Adj. EPS In Line With View - Quick Facts (RTTNews)
14.01.21	Integra LifeSciences Sees Q4 Revenue Below Estimates - Quick Facts (RTTNews)
16.12.20	Integra LifeSciences To Acquire ACell For Up To $400 Mln In Cash - Quick Facts (RTTNews)
28.10.20	Integra LifeSciences Q3 Profit Tops Estimates; Revenues Down 1.5% On Organic Basis (RTTNews)
29.09.20	Smith+Nephew To Acquire Extremity Orthopaedics Unit Of Integra - Quick Facts (RTTNews)
07.05.20	Integra LifeSciences Posts Lower Q1 Profit (RTTNews)
19.02.20	Integra LifeSciences Q4 Profit Tops View, But Revenues Miss (RTTNews)
23.09.19	Integra LifeSciences Supports the European Burns Association’s “Share your Care” Educational Program (GlobeNewswire)
25.07.19	6 Top Gainers In Healthcare Sector (GHDX, THC, IART…) (RTTNews)
24.07.19	Integra LifeSciences Raises FY19 Adj. EPS Outlook, Q2 Profit Surges (RTTNews)
08.01.19	Integra LifeSciences Sees Q4 Revenue At Higher End Of Prior Guidance (RTTNews)
31.10.18	Integra LifeSciences Backs FY18 Adj. EPS Outlook, Q3 Profit Surges - Quick Facts (RTTNews)
25.07.18	Integra LifeSciences Updates 2018 Outlook - Quick Facts (RTTNews)
01.06.18	Evergy Set to Join S&P 500; Navient and Integra Lifesciences Holdings to Join S&P MidCap 400; Ambac Financial Group to Join S&P SmallCap 600 (PR Newswire)
25.04.18	Integra LifeSciences Q1 Profit Rises; Lifts 2018 Outlook (RTTNews)
27.02.18	Integra LifeSciences Q4 Profit Surges; Results Beat View (RTTNews)
08.01.18	Integra LifeSciences Sees Q4 Revenue Above View (RTTNews)
11.12.17	Integra LifeSciences Reaffirms Earnings View For FY17, FY18 - Quick Facts (RTTNews)
26.10.17	Integra LifeSciences Updates 2017 Outlook (RTTNews)
26.10.17	Integra LifeSciences Q3 Profit Falls, Cuts FY17 Profit Outlook (RTTNews)
04.10.17	Integra LifeSciences bringt Integra®SurgiMend(TM) PRS Meshed-Kollagenmatrix für Brustrekonstruktionen in Europa auf den Markt (GlobeNewswire)
03.10.17	Integra LifeSciences Launches Integra® SurgiMend(TM) PRS Meshed Collagen Matrix for Breast Reconstruction in Europe (GlobeNewswire)
02.10.17	Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson (GlobeNewswire)
11.09.17	Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated (GlobeNewswire)
06.09.17	Landmark M&A Deals Continue to Shape Big Pharma (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

04.11.24		Verluste in New York: NASDAQ Composite beendet die Montagssitzung mit Verlusten
04.11.24		Freundlicher Handel: NASDAQ Composite am Montagnachmittag auf grünem Terrain
04.11.24		Börse New York in Rot: NASDAQ Composite gibt am Mittag nach
04.11.24		Verluste in New York: NASDAQ Composite beginnt Montagshandel mit Verlusten
10.10.24		Minuszeichen in New York: NASDAQ Composite notiert zum Handelsende im Minus
10.10.24		NASDAQ Composite-Handel aktuell: NASDAQ Composite verbucht Abschläge
10.10.24		NASDAQ Composite-Handel aktuell: NASDAQ Composite zeigt sich fester
10.10.24		NASDAQ Composite aktuell: NASDAQ Composite beginnt Handel mit Verlusten

04.11.24

Verluste in New York: NASDAQ Composite beendet die Montagssitzung mit Verlusten

04.11.24

Freundlicher Handel: NASDAQ Composite am Montagnachmittag auf grünem Terrain

04.11.24

Börse New York in Rot: NASDAQ Composite gibt am Mittag nach

04.11.24

Verluste in New York: NASDAQ Composite beginnt Montagshandel mit Verlusten

10.10.24

Minuszeichen in New York: NASDAQ Composite notiert zum Handelsende im Minus

10.10.24

NASDAQ Composite-Handel aktuell: NASDAQ Composite verbucht Abschläge

10.10.24

NASDAQ Composite-Handel aktuell: NASDAQ Composite zeigt sich fester

10.10.24

NASDAQ Composite aktuell: NASDAQ Composite beginnt Handel mit Verlusten

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Integra LifeSciences Holdings Corp.

Aktien Top/Flop

Integra LifeSciences Holdings Peer Group Nachrichten

Meistgelesene Nachrichten